GSK Found No Asthma Deaths From COPD Drug, FDA Reports
GlaxoSmithKline PLC's medication for chronic obstructive pulmonary disease Breo Ellipta did not cause any asthma-related fatalities in a series of clinical studies conducted by the drugmaker, the U.S. Food and Drug...To view the full article, register now.
Already a subscriber? Click here to view full article